[1]
Mykhaloiko, I.S., Yatsyshyn, R.I., Dudar, I.O., Hotsaniuk, O.I. and Kuryliv, H.M. 2025. Safety and efficacy of apixaban in patients with glomerulonephritis and nephrotic syndrome: a prospective longitudinal cohort study. Modern medical technology. 17, 1 (Mar. 2025), 41–45. DOI:https://doi.org/10.14739/mmt.2025.1.320766.